Literature DB >> 2834422

Pure and mixed mucinous breast carcinomas: DNA stemline and prognosis.

S Toikkanen1, E Eerola, T O Ekfors.   

Abstract

The DNA stemline of 45 mucinous breast carcinomas was determined by flow cytometry using paraffin embedded archival tissue sections. The material consisted of 26 pure mucinous and 19 mixed mucinous carcinomas. The patients were followed up for at least 15 years or until death. Nearly all pure mucinous carcinomas had a normal DNA stemline (25 of 26) with only one aneuploid tumour. Mixed mucinous carcinomas had a DNA content resembling that of common ductal carcinoma with 11 aneuploid tumours. Aneuploid tumours tended to be of higher grade and stage than diploid tumours. The survival of patients with pure mucinous carcinoma was better than that of patients with mixed mucinous carcinoma. Mucinous carcinoma should be classified as such only if it is a pure mucinous carcinoma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2834422      PMCID: PMC1141428          DOI: 10.1136/jcp.41.3.300

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

1.  PROGNOSIS OF MUCINOUS (GELATINOUS) CARCINOMA OF THE BREAST.

Authors:  H J NORRIS; H B TAYLOR
Journal:  Cancer       Date:  1965-07       Impact factor: 6.860

2.  Colloid carcinoma of the breast.

Authors:  S G Silverberg; S Kay; A R Chitale; S H Levitt
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

3.  Pure mucinous carcinomas of breast: morphologic features and prognostic correlates.

Authors:  F Clayton
Journal:  Hum Pathol       Date:  1986-01       Impact factor: 3.466

4.  Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer.

Authors:  T E Kute; H B Muss; M Hopkins; R Marshall; D Case; L Kammire
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

5.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

Authors:  D W Hedley; M L Friedlander; I W Taylor; C A Rugg; E A Musgrove
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

6.  Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor.

Authors:  W Olszewski; Z Darzynkiewicz; P P Rosen; M K Schwartz; M R Melamed
Journal:  Cancer       Date:  1981-08-15       Impact factor: 6.860

7.  Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients.

Authors:  D W Hedley; C A Rugg; A B Ng; I W Taylor
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

8.  A proposed classification of breast cancer based on kinetic information: derived from a comparison of risk factors in 168 primary operable breast cancers.

Authors:  R W McDivitt; K R Stone; R B Craig; J O Palmer; J S Meyer; W C Bauer
Journal:  Cancer       Date:  1986-01-15       Impact factor: 6.860

9.  Surgical treatment of carcinoma of the breast: III. Pathological finding and probability of relapse.

Authors:  Y T Lee
Journal:  J Surg Oncol       Date:  1984-02       Impact factor: 3.454

10.  Relationship between ploidy and steroid hormone receptors in primary invasive breast cancer.

Authors:  D J Horsfall; W D Tilley; S R Orell; V R Marshall; E L Cant
Journal:  Br J Cancer       Date:  1986-01       Impact factor: 7.640

View more
  8 in total

1.  Oestrogen receptors in mucinous carcinoma of the breast: an immunohistological study using paraffin wax sections.

Authors:  S Shousha; A T Coady; T Stamp; K R James; J Alaghband-Zadeh
Journal:  J Clin Pathol       Date:  1989-09       Impact factor: 3.411

2.  Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous features.

Authors:  Purevsuren Jambal; Melanie M Badtke; J Chuck Harrell; Virginia F Borges; Miriam D Post; Grace E Sollender; Monique A Spillman; Kathryn B Horwitz; Britta M Jacobsen
Journal:  Breast Cancer Res Treat       Date:  2012-12-18       Impact factor: 4.872

3.  Prognosis of subtypes of the mucinous breast carcinoma in Chinese women: a population-based study of 32-year experience (1983-2014).

Authors:  Bo Pan; Ru Yao; Jie Shi; Qian-Qian Xu; Yi-Dong Zhou; Feng Mao; Yan Lin; Jing-Hong Guan; Xue-Jing Wang; Yan-Na Zhang; Xiao-Hui Zhang; Song-Jie Shen; Ying Zhong; Ya-Li Xu; Qing-Li Zhu; Zhi-Yong Liang; Qiang Sun
Journal:  Oncotarget       Date:  2016-06-21

4.  Histopathological analysis of mucinous breast cancer subtypes and comparison with invasive carcinoma of no special type.

Authors:  Michał Piotr Budzik; Marta Magdalena Fudalej; Anna Maria Badowska-Kozakiewicz
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

5.  Pure mucinous carcinoma of the breast: clinicopathologic characteristics and long-term outcome among Taiwanese women.

Authors:  Hsin-Shun Tseng; Che Lin; Szu-Erh Chan; Su-Yu Chien; Shou-Jen Kuo; Shou-Tung Chen; Tsai-Wang Chang; Dar-Ren Chen
Journal:  World J Surg Oncol       Date:  2013-06-14       Impact factor: 2.754

6.  The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up.

Authors:  S Toikkanen; H Joensuu; P Klemi
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

7.  Clinicopathological and genomic features of breast mucinous carcinoma.

Authors:  Kebin Lu; Xiao'e Wang; Wenyuan Zhang; Hui Ye; Lingling Lao; Xiaodong Zhou; Sijie Yao; Feng Lv
Journal:  Breast       Date:  2020-08-06       Impact factor: 4.380

Review 8.  Mucinous breast cancer: A narrative review of the literature and a retrospective tertiary single-centre analysis.

Authors:  Emilia Marrazzo; Federico Frusone; Flavio Milana; Andrea Sagona; Wolfgang Gatzemeier; Erika Barbieri; Alberto Bottini; Giuseppe Canavese; Arianna Olga Rubino; Marco Gaetano Eboli; Carlo Marco Rossetti; Alberto Testori; Valentina Errico; Alessandro De Luca; Corrado Tinterri
Journal:  Breast       Date:  2019-11-11       Impact factor: 4.380

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.